::
In a previous post, I mentioned the rigorous process a candidate drug is subjected to before it gets a nod by drug authorities.
India is currently seeing a burgeoning clinical research industry. The institutes that offer such courses claim that India is going to be a global hub for R & D in clinical research and thus there are going to be ample opportunities in clinical research.
However given the kind of country India has become, practically anything can be spurious here! So there are a few concerns I have:
(1) Is it possible that the great Indian hub becomes a hunting ground where foreign multinational companies bypass stringent policies adopted in their host nation(s)?
(2) Would it jeopardize the interests of Indian patients who may be lured by the "foreign component" in the tag?
There have been cases where Indian hospitals or doctors have indulged in dubious practices just to be in the lime light. I am sure many would recall, a doctor couple got their teenager son to carry out a Cesarean section on a pregnant lady just that they could announce him to be the youngest person to have accomplished the "feat". Currently another government hospital is in news for wrong reason: a team in a hospital based in Madurai, Tamilnadu, India carried out over a dozen breast surgeries (lumpectomy) for breast growth in a "record time" of three and half hours!
So if you are a patient with a chronic or incurable disease, don't jump and participate in a clinical trial. Seek advise.
More to follow....
::
Posts
No comments:
Post a Comment